TipRanks
Go Ultimate55% OFF

Matthew Kapusta Insider Profile

11 Followers

Matthew Kapusta, CEO, Managing Director, Director at uniQure, holds 519.23K shares in uniQure (Ticker: QURE), holds 0.00 shares in Decibel Therapeutics (Ticker: DBTX), holds 30.06K shares in AngioDynamics (Ticker: ANGO).

Matthew Kapusta's Trading History

QURE
uniQure
Jul 07, 2026CEO, Managing Director, DirectorUninformative Buy408.78K$12.89M
DBTX
Decibel Therapeutics
Sep 25, 2023―Uninformative Sell―$0.00
ANGO
AngioDynamics
Nov 19, 2014SVP BDUninformative Sell23.46K$360.44K

You May Also Like

Matthew Kapusta insider profile FAQ

What is the percentage of profitable transactions made by Matthew Kapusta?
The percentage of profitable transactions made by Matthew Kapusta is 44%.
What is the average return per transaction made by Matthew Kapusta?
The average return per transaction made by Matthew Kapusta is -19.50%.
What stocks does Matthew Kapusta hold?
Matthew Kapusta holds: QURE, ANGO, DBTX stocks.
What was Matthew Kapusta’s latest transaction?
Matthew Kapusta’s latest transaction was an Uninformative Buy of $408.78K.
What was Matthew Kapusta's most profitable transaction?
Matthew Kapusta’s most profitable transaction was an Informative Sell of QURE stock on March 9, 2023. The return on the trade was 74.30%.
What is Matthew Kapusta's role in uniQure?
Matthew Kapusta's role in uniQure is CEO, Managing Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.